DeviceTalks Podcast Network

In this episode of the DeviceTalks Weekly Podcast, Managing Editor Kayleen Brown sits down with Johnson & Johnson MedTech Heart Recovery Worldwide President Devi Govender at DeviceTalks Boston. Govender shares how a deeply personal family experience shaped her mission to transform cardiovascular care. She reflects on Abiomed's integration into Johnson & Johnson, the evolution of heart recovery therapies, and why the industry must shift its mindset from treating "heart failure" to enabling "heart recovery." The discussion explores patient-centered innovation, AI, clinical evidence, and the power of combining technologies, data, and advocacy to redefine the future of cardiovascular care for patients around the world. This episode is sponsored by  Freudenberg Medical. Listen for a conversation with Shane Healy, Senior Director of Technology. Visit FreudenbergMedical.com for more information. We'll kick off this episode with Newmarker's Newsmakers. Host Tom Salemi and MassDevice Editor Chris Newmarker revisit the top MedTech stories of the week: Zeta Surgical, Hologic, Medtronic, Fractyl Health, and Vicarious Surgical. --- Enjoy the show? Follow DeviceTalks Weekly on all major podcast platforms, and subscribe to YouTube.com/@DeviceTalks so you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Subscribe today at [https://devicetalks.castos.com/subscribe](https://devicetalks.castos.com/subscribe). Chapters (00:09:10) - Zeta wins FDA clearance for TMS robotic stereotactic system(00:13:01) - Private equity firms reportedly set $4B price on Hologic Surgical unit(00:15:03) - Medtronic, FDA pick up legal victories in spinal cord stimulator suits(00:16:20) - Fractyl Health says its single-catheter treatment maintained most GLP-1 weight loss(00:22:17) - Vicarious Surgical's board wants to shut down and liquidate the robotics developer(00:29:53) - Interview with Shane Healy, Senior Director of Technology, Freudenberg Medical(00:36:53) - Keynote interview with Devi Govender, Worldwide President, Heart Recovery, Johnson & Johnson MedTech

In this episode of DeviceTalks Weekly, Host Tom Salemi explores the breakthrough technologies—and the unique culture—driving one of MedTech's most ambitious missions with XCATH CEO Eduardo Fonseca. Fonseca shares the remarkable story behind XCATH's first remote robotic stroke procedure. Fonseca recounts the years of preparation, the high-stakes operation, and the emotional moment when a patient facing severe disability walked away with what he calls "a second birthday." Along the way, Tom and Eduardo discuss AI's growing role in surgery, the global shortage of stroke specialists, the future of robotic intervention, and why expanding access—not simply advancing technology—is the company's ultimate goal.To learn more about XCATH and talk with Fonseca, join us on July 29 for a live DeviceTalks discussion. Register here for the free webinar. Thank you to our sponsors Confluent, Jabil, Maxon, Solesis, Viant, and VitalPath. MassDevice Editor Chris Newmarker returns to deliver this episode’s Newmarker’s Newsmakers – MDUFA, Corza Medical, Resmed, GTCR, Zimmer Biomet, Pacira Biosciences, and Johnson & Johnson MedTech.  *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:36) - FDA releases draft MDUFA VI agreement outlining proposed legislation and program changes(00:12:50) - Resmed to sell MatrixCare software business to private equity firm for $490M/ GTCR to divest Biosurgery unit of Corza Medical(00:15:58) - Medtronic’s chief sustainability officer is departing(00:17:55) - Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences(00:19:56) - Johnson & Johnson wins FDA approval for ThermoCool SmartTouch dual-energy ablation system

In this episode of the DeviceTalks Weekly Podcast, host Tom Salemi is reassured by his conversation with Joe Catanese, CEO of Calyxo, a urology startup that has developed a system designed to simplify kidney stone removal. Catanese previously helped build Neotract, a urology startup that was acquired by Teleflex for more than $1 billion. Now, he's leading another potential gamechanger and may have his sights set on an IPO. Speaking of gamechangers, HistoSonics continues to shatter fundraising expectations. The company recently completed a financing round that valued it at $3.75 billion. In this week's FOMO interview, HistoSonics President and CEO Mike Blue speaks with MassDevice Editor Chris Newmarker during a keynote conversation at DeviceTalks Minnesota. In this excerpt, Blue reflects on the company's first major fundraising round, which attracted high-profile investors including Jeff Bezos and Peter Thiel, and shares his perspective on just how large the opportunity for histotripsy could become. But first, Tom and Jim Hammerand, managing editor of Medical Design & Outsourcing, discuss AI—or LLMs, or whatever term you prefer. Is the hype beginning to fade? And what should the industry make of the recent announcement from Midjourney Medical? *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - AI Talk with Jim Hammerand, managing editor, Medical Design & Outsourcing(00:24:46) - DeviceTalks Minnesota interview excerpt - Mike Blue, CEO and President, Histosonics(00:41:44) - Keynote Interview with Joe Catanese, CEO and President, Calyxo

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi visits his MedTech happy place — renal denervation — with Recor Medical COO Helen Reeve Stoffer. Reeve Stoffer joined the company shortly before the bottom fell out of the renal denervation market in 2014. This interview picks up from that point and follows Recor's pursuit of FDA approval to where denervation technology may be applied next. This week’s FOMO features a portion of a keynote interview with Manny Villafaña, MedTech legend and CEO of Medical 21. The conversation took place at DeviceTalks Minnesota and focuses on the dream that saved St. Jude Medical. Skyler Rivera, associate editor of MassDevice, gives us a preview of her upcoming feature in Medical Design & Outsourcing magazine on the race to provide telesurgery capabilities to surgical robotic systems. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:42) - Associate Editor Skyler Rivera's path the MedTech (and MassDevice)(00:06:00) - MDO covers the race for robotic telesurgery platforms in stroke(00:11:12) - Rivera reviews the race leaders(00:16:30) - FOMO Studio - Manny Villafana, MedTech Legend and CEO of Medical 21(00:28:19) - Keynote Interview - Helen Reeve Stoffer, COO, Recor Medical

In this episode, Host Tom Salemi is joined by Darla Hutton, Intuitive’s global vice president of cardiac surgery, to discuss the surgical robotics giant’s return to cardiac surgery. Intuitive famously aimed for the heart at its outset but pivoted when cardiac surgery proved too complicated. Today, heart patients and surgeons are pushing for minimally invasive procedures, and Hutton, a former cardiac surgery OR nurse, has been tapped to lead the company’s push into an increasingly competitive specialty. But first, Harmonic Drive’s Bill Frey, regional sales engineer, joins us in the FOMO Studio. Go to HarmonicDrive.net for more information. Filling in for MassDevice’s Chris Newmarker, Senior Editor Sean Whooley wraps up the five biggest stories to come out of the American Diabetes Association meeting — Abbott, Senseonics, Sequel, Dexcom, and Insulet. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:43) - Abbott studies reinforce DKA opportunity following dual sensor milestone(00:07:13) - Senseonics study supports Eversense 365 CGM with automated insulin delivery tech(00:09:20) - Sequel Med Tech data supports twiist automated insulin delivery in type 2 diabetes(00:11:18) - Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes(00:13:01) - Insulet data backs Omnipod 6, fully closed-loop AID systems(00:16:29) - FOMO Studio - Bill Frey, regional sales engineer, Harmonic Drive(00:27:14) - Keynote Interview - Darla Hutton, Global Vice President, Cardiac Surgery Intuitive

In this episode of DeviceTalks Weekly, Tom Salemi talks with Wayne Allen, the co-founder and CEO of Perfuze, an Irish company developing a novel new way of blood clot aspiration. Allen and his co-founder already executed one successful exit earlier in their careers. Can they find success again with Perfuze? This episode is sponsored by DeviceTalks Boston. Go to Boston.DeviceTalks.com to register. Use the code DTW25 to save 25%. MassDevice Editor Chris Newmarker opens up the podcast with this week’s top stories from the pages of MassDevice – Masimo, Danaher, ResMed, Johnson & Johnson MedTech, and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:00) - Quick recap of DeviceTalks Minnesota(00:07:05) - MassDevice’s Orthopedic Device Companies Special Report for 2026(00:08:20) - Masimo shareholders give green light to $10B acquisition by Danaher(00:09:56) - ResMed enters merger agreement to acquire Noctrix Health for $340 million(00:14:03) - Johnson & Johnson says Ottava surgical robot met endpoints in pivotal bariatric surgery study(00:15:45) - Medtronic merges Cardiac Surgery, Aortic units into Cardiovascular Surgery business(00:19:45) - FOMO Studio – Yossi Bar, CEO, LEM Surgical(00:31:22) - Keynote Interview- Wayne Allen, CEO, Perfuze

In this episode, Host Tom Salemi and Holly Scott, senior partner at The Mullings Group, preview the upcoming DeviceTalks Minnesota agenda. Join us on May 4 at the McNamara Alumni Center! If you haven’t registered, use the code DTW25 to save 25% off the price of registration, visit https://minnesota.devicetalks.com/. MassDevice Editor Chris Newmarker also delivers this week’s top newsmakers on the pages of MassDevice—HRS 2026, Johnson & Johnson, Stryker, Medtronic, and Teleflex. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:07:25) - The top cardiac tech stories out of HRS 2026(00:09:03) - Johnson & Johnson launches head-to-head PFA trial pitting Varipulse against Boston Scientific’s Farapulse(00:10:16) - Stryker results miss after Q1 cyberattack; company sticks with guidance(00:11:43) - Medtronic discloses cybersecurity breach in certain IT systems(00:15:30) - Teleflex picks Medtronic Coronary & Renal Denervation leader Weidman as new CEO

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Michael Carter, SVP, President, Cranial & Spinal Technologies about the company’s deployment of robotics, AI and other tech. Managing Editor Kayleen Brown hosts Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru, on this weeks’ FOMO. MassDevice Editor Chris Newmarker highlights the MassDevice newsmakers – Stereotaxis, Robocath, Prosomnus, Johnson & Johnson MedTech, Avanos Medical, Stryker and Amplitude Vascular Systems. Thanks to Greenlight Guru for sitting in our FOMO studio! Download its QMSR readiness playbook, it's everything you need to get compliant with QMSR, all in one place: https://www.greenlight.guru/qmsr-readiness-playbook-free-download If you haven’t registered for DeviceTalks Minnesota or DeviceTalks Boston, use the code DTW25 to save 25% ***Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe  Chapters (00:01:25) - Discount Code for DeviceTalks events(00:03:11) - MassDevices' Newmarker's Newsmakers(00:05:25) - Stereotaxis to acquire Robocath for up to $45M(00:09:02) - ProSomnus gets FDA nod for latest sleep apnea therapy device(00:12:08) - - Johnson & Johnson ups 2026 outlook on Q1 beats, MedTech sales rise 7.7%(00:15:11) - Avanos Medical agrees to be acquired by private equity firm in $1.3B deal(00:16:22) - Stryker makes IVL play with agreement to acquire Amplitude Vascular Systems(00:18:06) - FOMO Guest: Etienne Nichols, Head of Industry Insights & Education, Greenlight Guru(00:31:55) - Keynote Interview- Michael Carter, SVP President, Cranial & Spinal Technologies, Medtronic

In this episode of the DeviceTalks Women in MedTech podcast, Host Kayleen Brown sits down with Gaele Lalahy, Chief Operating Officer at Plexāā, to discuss what it looks like to treat patients as true co-designers, not only in product development but across the entire pre-surgery experience. Lalahy shares the clinical foundation behind BLOOM⁴³, Plexāā’s wearable, at-home device used the night before breast surgery to increase blood flow and support healing through supraphysiological preconditioning, and explains how Plexāā pairs the device with a holistic app that helps patients feel prepared, informed, and supported before and after surgery. Kayleen also welcomes Tom Salemi, Editorial Director of DeviceTalks, for an in-studio conversation that connects the episode’s theme to the broader MedTech ecosystem, including a look ahead at DeviceTalks Minnesota, May 4 and DeviceTalks Boston, May 27–28. Together, they discuss how listening to the end user shapes better outcomes, better experiences, and better leadership. * Mentioned in the interview * Check out this DeviceTalks Weekly episode featuring Samay's CEO Maria Artunduaga: https://www.devicetalks.com/how-samays-ceo-came-up-with-the-sound-idea-for-a-device-to-battle-copd-win-medtech-innovator/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:08) - Intro to theme: patient as co‑designer(00:03:38) - Interview with In-Studio guest, Tom Salemi(00:04:29) - DeviceTalks Minnesota (May 4) & DeviceTalks Boston (May 27–28) preview(00:14:17) - Keynote interview with Gaele Lalahy, COO, Plexāā(00:15:59) - Gaele’s origin story: gymnast mindset, Panasonic, and “unlearning” into MedTech(00:26:50) - Plexāā + BLOOM⁴³ explained: reducing complications with supraphysiological preconditioning(00:39:55) - Leadership + allyship: building teams, saying yes, and mentor shout-outs

In this episode of the DeviceTalks Weekly Podcast, OrthAlign CEO Eric Timko explains how he’s built two successful companies in the wake of surgical robotics’ rise in orthopedics. He also shares sage advice from his father—words that ultimately led him to a career in medical devices.This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off registration.In this week’s Newmarker’s Newsmakers, Host Tom Salemi shares his experience from MedTech Innovator’s Radar Forum. Then he and Chris Newmarker review the biggest news on MassDevice: Stryker, Johnson & Johnson MedTech, Intuitive, Baxter, and the Transcatheter Heart Valves Special Report. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:30) - MedTech Innovator Radar Forum(00:09:30) - MassDevice’s Transcatheter Heart Valves Special Report(00:11:08) - Stryker operations fully restored after cyberattack(00:14:55) - Johnson & Johnson brings next-gen Varipulse PFA catheter to Europe(00:16:30) - Former Intuitive EVP Brian Miller joins Sovato as CEO(00:21:18) - Former Baxter CEO takes the corner office at Hologic as go-private deal closes(00:26:20) - Keynote interview: Eric Timko, CEO, OrthAlign

In this episode of the DeviceTalks Weekly podcast, Amaza Reitmeier shares with Host Tom Salemi why she left the company she never thought she’d leave — Medtronic — to lead Pharaoh Neuro, a company developing a novel approach to treating stroke patients by removing harmful blood from cerebrospinal fluid. Reitmeier shares lessons from her own career and her mentors on timing big moves, learning what you don’t know, and why some of MedTech’s biggest opportunities remain hidden in plain sight. This episode is sponsored by DeviceTalks Minnesota. Register at Minnesota.DeviceTalks.com and use the code DTW25 to save 25% off the registration fee. Salemi and MassDevice Editor Chris Newmarker offer encouragement to exercising listeners while delivering this week’s Newmarker’s Newsmakers — including updates on cardiology companies, HistoSonics, Boston Scientific, Johnson & Johnson MedTech, Abbott, the Mayo Clinic, and WHOOP. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:08:12) - The biggest cardiology tech stories out of ACC 2026(00:11:45) - HistoSonics kicks off study using Edison histotripsy system in BPH(00:14:20) - Boston Scientific completes Valencia Technologies acquisition(00:16:00) - Johnson & Johnson MedTech shares findings for Impella CP in left ventricle support(00:16:27) - Abbott joins $575M funding round for wearable maker WHOOP(00:22:20) - Keynote Interview, Amaza Reitmeier, CEO, Pharaoh Neuro

In the final episode of AbbottTalks season 3, hosts Tom Salemi and Kayleen Brown sit down with Rebecca Wilkins, divisional vice president of R&D for Abbott’s Neuromodulation business, to discuss the technologies Abbott is advancing for chronic pain and movement disorders.Wilkins explains how Abbott’s spinal cord stimulation platforms, Proclaim™ DRG Neurostimulation System, and Infinity™ deep brain stimulation system are designed to interrupt errant nervous system signals, helping patients manage conditions ranging from chronic pain and Parkinson’s disease to, potentially, treatment-resistant depression.The conversation also highlights the features shaping Abbott’s neuromodulation portfolio, including Bluetooth-enabled connectivity, the NeuroSphere™ Virtual Clinic for remote programming, improved MRI compatibility including prone MRI access, and device options that balance small size with low recharge demands.Wilkins also shares new data presented at NANS showing significant reductions in pain-related healthcare encounters for patients using Abbott’s spinal cord stimulation and DRG therapies. This episode is brought to you by Confluent Medical Technologies. To learn more about Confluent, visit: https://confluentmedical.com/. Make sure to catch Confluent's March DeviceTalks Tuesdays webinar highlighting its new technology, Filmcast Select™: https://event.on24.com/wcc/r/5241831/7E70E13249532E05CA8FB3D51421AD71?partnerref=confluent *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Intro: Reflecting on Season 3(00:05:22) - (Part 1) Interview with Confluent Medical's Brittany Mai(00:07:56) - Keynote Interview: Rebecca Wilkins, DVP of R&D at Abbott’s neuromodulation business(00:13:57) - A Personal Connection: How DBS Impacted a Family(00:16:21) - Innovation in Connectivity: Bluetooth and NeuroSphere™ Virtual Clinic(00:21:37) - (Part 2) Interview with Confluent Medical's Brittany Mai(00:24:42) - Targeted Therapy: Understanding Spinal Cord and DRG Stimulation(00:32:37) - Breaking Barriers: MRI Compatibility and Device Longevity(00:36:04) - New Data from NANS: Validating Patient Outcomes

In this episode of DeviceTalks Weekly, Medtronic’s Blake Tatum, Vice President of U.S. Commercial for Acute Care & Monitoring, joins Host Tom Salemi to unpack the evolving patient monitoring landscape. Tatum shares how Medtronic is integrating sensors, data, and digital health to support clinicians from the ICU to the home, why partnerships are reshaping the competitive playbook, and how lessons from the pandemic are driving a new focus on accuracy, equity, and connectivity in care delivery. This episode is sponsored by DeviceTalks Minnesota. Go to Minnesota.Devicetalks.com to check out the amazing agenda! Then Salemi and MassDevice editor Chris Newmarker review this week’s MedTech newsmakers including surgical robotics, Abbott, Stryker, Boston Scientific, and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:15) - 10 surgical robotics companies you need to know (Go to MassDevice.com to download the report)(00:08:09) - Abbott completes Exact Sciences acquisition(00:09:37) - Stryker reportedly brings most services affected by cyberattack back online(00:11:20) - Boston Scientific has reportedly had pacemaker battery problems for years(00:14:01) - Round up of Medtronic News(00:21:30) - Keynote interview with Medtronic’s Blake Tatum

In this episode of DeviceTalks Weekly, Distalmotion CEO Greg Roche updates Host Tom Salemi on the surgical robotics company’s commercial roll out of Dexter, a robotic system designed for ambulatory surgery centers. Roche shares the lessons he’s learned after a decade in surgical robotics and why he’s particularly optimistic about his company’s outcome. You can hear Greg Roche’s first appearance on the podcast right here: https://www.devicetalks.com/why-distalmotions-roche-sees-dexters-small-size-as-big-advantage-in-the-robotics-surgical-market/  This episode is sponsored by DeviceTalks Boston. Register at Boston.DeviceTalks.com. Use the code DTW25 to save 25% off the registration price. Rachel Robinson, COO of MassMEDIC, joins the MassDevice Newmarker’s Newsmakers with Salemi and Editor Chris Newmarker – Stryker, CMR Surgical, Revolve Surgical, JenaValve, and MassDevice’s Surgical Robotics Special Report for 2026. You can download the report with 70+ profiles of surgical robotics companies here - https://www.massdevice.com/surgical-robotics-special-report-2026/ Robinson also welcomes listeners to attend MassMEDIC’s Symposium & Gala on April 2. Go to MassMEDIC.com to see the agenda and to register. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:15) - MassMEDIC COO Rachel Robinson discusses the Medtech Impact Symposium & Gala(00:10:05) - MassDevice’s Surgical Robotics Special Report for 2026(00:11:58) - Stryker CEO Kevin Lobo joins GE HealthCare board of directors(00:14:35) - CMR Surgical, Nvidia collab to train next-gen surgical robots(00:18:02) - Revolve Surgical wins FDA clearance for surgical robot(00:21:00) - JenaValve wins FDA nod for Trilogy heart valve system(00:25:45) - Keynote Interview – Greg Roche, CEO, Distalmotion

In this episode of the DeviceTalks Weekly podcast, Stephen From, the new CEO of Vicarious Surgical, explains why he jumped the chasm from biotech to lead surgical robotics company Vicarious Surgical. From brings years of experience bringing products to market and he lays out the plan for Vicarious’s single-incision robot to Host Tom Salemi. Next, Salemi interviews Bill Frey, Regional Sales Engineer, Harmonic Drive, about the unique challenges of surgical robotics. For more information about Harmonic Drive, go to www.harmonicdrive.net. But we’ll start off with Salemi and MassDevice Editor Chris Newmarker discussing this week’s Newmarker’s Newsmakers – Petal Surgical, Abbott, Stryker, and Medtronic. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:50) - Chris and Tom talk turkeys(00:06:20) - Incisionless surgical robot developer Petal Surgical adds more funding, Fred Moll joins board(00:09:50) - Abbott completes $20B offering for Exact Sciences buy(00:12:02) - Stryker launches SmartHospital platform to elevate care delivery(00:15:00) - Stryker reportedly hit with Iran-backed cyberattack(00:16:41) - Medtronic makes neurovascular play with $550M Scientia Vascular buy(00:18:55) - FOMO - Bill Frey, Regional Sales Engineer, Harmonic Drive(00:30:05) - Keynote Conversation, Stephen From, CEO, Vicarious Surgical

In this episode of the DeviceTalks Weekly podcast, Jessica Mathieson, president of Stryker’s medical business, takes Host Tom Salemi to the frontlines of healthcare, where hospitals are seeking support for healthcare professionals. Mathieson will explain how the acquisitions of Vocera and Care AI have enabled Stryker to build a comprehensive communications and monitoring tool that can keep nurses safe while improving patient care. Find Mathieson’s first visit to DeviceTalks here: https://www.stryker.com/us/en/about/news/2022/acute-care-s-mathieson-explains-how-vocera-fits-into-stryker-s-g.html And as an added bonus, on Monday, March 9th, Stryker announced that it launched its new SmartHospital platform. Learn more here: https://www.massdevice.com/stryker-launches-smarthospital-platform-care-delivery/ In this week’s FOMO, Ignacio Pedrosa, Advanced Solutions Engineer at Novanta, talks with Kayleen Brown about the company’s work to make surgical robotic systems smaller, smarter and more capable. For more information, go to https://novanta.com. In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker and Salemi talk about their favorite flavor of Girl Scout cookie. (Buy yours in the link below) before talking about the top stories of the week – Smith & Nephew, Science Corp., Boston Scientific, Medtronic and, in a bit of Meta-ness – an article about Jenny Barba’s appearance on the podcast two weeks ago! Go here to buy cookies from Chris’s daughter! - https://digitalcookie.girlscouts.org/scout/stella590572 *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe  Chapters (00:05:42) - Smith+Nephew posts Q4 sales beat amid overall strategy shift(00:07:39) - 3 tips for first-time medtech entrepreneurs from a venture capital pro(00:09:51) - Science Corp. closes $230M Series C to support BCI tech(00:13:27) - Boston Scientific wins expanded CE mark for Farapulse in persistent AFib(00:17:01) - Medtronic, GE HealthCare expand strategic alliance

In this episode, Armor Medical Co-founder and CEO Kelsey Mayo shares her ultimate entrepreneurial journey. Mayo recognized early on that her career needed to make an impact, but the focus of her passion became clear after a frightening experience of her own. Today, she’s CEO of a startup building a wearable device that can serve as an early warning system for hemorrhaging. This could immediately protect the lives of women giving birth and ultimately replace guesswork with irrefutable data. Armor Medical won MedTech Innovator’s top award at AdvaMed in the fall. This episode is sponsored by DeviceTalks Minnesota. Speaking of MedTech Innovator, CEO Paul Grand joins Tom Salemi and Chris Newmarker to analyze this week’s top Newsmakers from MassDevice — DePuy Synthes, Medtronic, Pharaoh Neuro, Stryker, and Boston Scientific. Grand also introduced MedTech Innovator’s Radar Forum: https://medtechinnovator.org/radarforum2026/ *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode.Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedTech Innovator Radar Forum(00:12:06) - Pharaoh Neuro raises $20M, names former Medtronic exec as CEO(00:15:05) - Medtronic MiniMed Diabetes unit prices IPO at up to $784M(00:20:40) - Medtronic wins CE mark for next-gen GI Genius module, ColonPRO software(00:22:50) - AHA, ACC issue guidelines for pulmonary embolism that affect Boston Scientific, Stryker(00:24:56) - Johnson & Johnson MedTech reportedly eyes $20B deal to sell DePuy Synthes ortho unit(00:34:13) - Keynote interview: Kelsey Mayo, Co-founder and CEO, Armor Medical

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown takes the helm, leading a keynote interview with Jenny Barba, co-founder of Features Capital. Barba shares her path into venture capital, identifies winning strategies for start-ups, and highlights some of the more exciting companies in the Features Capital portfolio. A special thanks to this episode’s sponsor, SHL Healthcare, for supporting DeviceTalks! Go to www.shl-healthcare.com for more information. As a special bonus, download SHL Healthcare's complimentary white paper highlighting the outcomes of using the combination of advanced sewing, welding, and electromechanical assembly here: https://www.devicetalks.com/wp-content/uploads/2026/02/SHL-Healthcare_Whitepaper_Integrated-Approach.pdf Kayleen Brown also leads our FOMO interview with Nick West, MD, chief medical officer of Shockwave Medical, part of Johnson & Johnson MedTech. They talk about the future calcium modification, intravascular lithotripsy, and the evolving treatment of vascular disease. We’ll start things off with Host Tom Salemi and Chris Newmarker of MassDevice reviewing the newsmakers of the week - BioVentrix, Medical 21, VB Spine, Augmedics, Medtronic, Danaher, and Masimo. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:47) - #5 BioVentrix & Medical 21 IPOs(00:10:24) - #4 VB Spine acquires Augmedics(00:11:35) - #3 Medtronic Stealth Access robotic system(00:13:14) - #2 Medtronic earnings & growth updates(00:17:00) - #1 Danaher to acquire Masimo(00:23:15) - FOMO Interview – Nick West, MD, Chief Medical Officer, Shockwave Medical, part of Johnson & Johnson MedTech(00:23:42) - Part 1 of our interview with Per Bjorkman, Chief Commercial Officer, SHL Healthcare(00:41:31) - Keynote Interview, Jenny Barba, co-founder, Features Capital

In this episode of DeviceTalks Weekly, Host Tom Salemi speaks with MedTech veteran Darrin Uecker about a career shaped by some of the industry’s most notable innovations and acquisitions. Uecker’s journey begins at Computer Motion, where he served as CTO through its historic acquisition by Intuitive Surgical. He recounts how that deal came together and traces the path that led him to senior leadership roles at multiple startups that ultimately achieved successful exits. Today, Uecker is chief technology officer at Pulse Biosciences, a small publicly traded company developing a next generation of pulsed-field ablation technology. He discusses the unconventional steps Pulse has taken to build its business, reviews the company’s latest clinical data, and shares his perspective on the future of the fast-moving PFA market. In our FOMO Interview, Ralph Kern, MD, chief medical officer of neuro startup Cognito Therapeutics, explains why he’s excited about technical advances in the field. He’s interviewed by Jim Hammerand, managing editor at Medical Design & Outsourcing magazine. As always we start the episode with MassDevice Editor Chris Newmarker and his top 5 stories of the week….aka Newmarker’s Newsmakers. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:15) - Karl Storz, Smith+Nephew partner on advanced surgical tech(00:06:32) - NextSense debuts brain activity-sensing headphones to improve sleep(00:11:17) - Medtronic stock gets a ratings boost on new products(00:12:40) - Johnson & Johnson MedTech has encouraging Omnypulse results, more data backs Varipulse(00:14:35) - Stryker says DOJ, SEC have closed bribery probes(00:16:40) - FOMO Interview – Ralph Kern, MD, Chief Medical Officer, Cognito Therapeutics(00:28:15) - Keynote Interview – Darrin Uecker, Chief Technology Officer, Pulse Biosciences(00:48:05) - The Pulse Biosciences stor

In this episode of DeviceTalks Weekly, CathWorks CEO Ramin Mousavi explains how the company built a surprisingly fast path to acquisition.Founded in 2013, the startup was forced to go back to the drawing board. By incorporating LLMs and other advances, CathWorks developed a better way to diagnose heart disease—leading to a strategic investment from Medtronic in 2022 and a full acquisition announced this week.Mousavi also shares his personal path into MedTech, including the unlikely story of an Iranian-American leading an Israel-based startup. In a conversation with Host Tom Salemi, he reflects on how employees kept the company’s mission front and center through constant change.In this week’s FOMO, Managing Editor Kayleen Brown draws on her own experience with Type 2 diabetes to explore how Dexcom is using data and AI. She speaks with Girish Naganathan, EVP and Chief Technology Officer at Dexcom.Plus, MassDevice Editor Chris Newmarker delivers Newmarker’s Newsmakers, featuring Medtronic, Siemens Healthineers, Stryker, Boston Scientific, and Applied Medical. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:38) - State of Minnesota / Newmarker’s Newsmakers(00:08:00) - Medtronic Structural Heart President Nina Goodheart to retire(00:09:11) - Siemens Healthineers unveils $12M R&D facility in Ireland(00:12:10) - Stryker officials have high hopes for 2026 with Mako RPS(00:13:54) - Boston Scientific posts Q4 beats as sales rise 16%, stock dips as EP sales come up short(00:16:19) - Medtronic reportedly must pay Applied Medical $382M over antitrust suit(00:21:52) - FOMO Interview – Girish Naganathan, EVP, Chief Technology Officer, Dexcom(00:32:28) - Keynote Interview – Ramin Mousavi, President, CEO, CathWorks

In this week’s episode of DeviceTalks Weekly, neurosurgeon Adam Arthur, MD, explains why he’s trading surgical scrubs for the chance to help lead Medtronic’s Neurovascular business as its new chief medical officer. Dr. Arthur joins Host Tom Salemi to discuss how neurosurgery is reaching more patients today—and what it must do to expand its impact in the years ahead. Before the keynote interview, Managing Editor Kayleen Brown speaks with Brittany Mai of Confluent Medical Technologies about the future of neuro and minimally invasive surgery. Thank you to Confluent for sponsoring this week’s episode. Learn more at ConfluentMedical.com. At the top of the show, MassDevice Editor Chris Newmarker talks with Wayne Paterson, CEO of Anteris Technologies, about the company’s new agreement with Medtronic and what it means for the future of TAVR. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:38) - Chris Newmarker interviews Wayne Paterson, CEO of Anteris Technologies(00:06:10) - This is not your Father’s TAVR(00:08:00) - Terms of the Medtronic investment(00:25:30) - Kayleen Brown sits down with Brittany Mai of Confluent Medical(00:29:50) - How is minimally invasive technology changing?(00:31:28) - Keynote conversation – Adam Arthur, MD, new chief medical officer for Medtronic Neurovascular(00:35:30) - What makes a good neurosurgeon?(00:39:01) - Choosing impact over intimacy(00:44:50) - What do patients fear more than death?(00:49:45) - More focus needed on Women’s neurological health including chronic refractory migraine

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Jupiter Endovascular CEO Carl St. Bernard about the “soft” design of the company's TFX technology, designed to simplify the complicated procedure of clearing cardiovascular blockages, including pulmonary artery embolisms. Jupiter is recording fundraising and clinical trials wins. St. Bernard shares what’s next. In this week’s FOMO, Kayleen Brown interviews Javier Olea, Life Science Segment Director at Averna about test and measurement in medical device manufacturing. Visit www.averna.com to learn more. We open the episode with this week’s Newsmakers compiled by MassDevice Editor Chris Newmarker – Merge, OpenAI, Abbott, Johnson & Johnson MedTech, Boston Scientific, Medtronic, Anteris Technologies. To register for our upcoming Cardiac Innovation series go here: https://event.on24.com/wcc/r/5203526/B4EE367D76F7ECCAC132665B50E61A7C/5516160?partnerref=Podcast *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:00) - #5 - OpenAI invests in Sam Altman’s Merge Labs BCI startup(00:08:30) - #4 - Abbott picks up CE mark for TactiFlex dual-energy ablation catheter(00:11:27) - #3 - Johnson & Johnson MedTech sales up 7.5% in Q4(00:13:24) - #2 - Boston Scientific has a potentially serious Axios stent recall(00:15:00) - #1 - Medtronic to invest up to $90M in Anteris Technologies(00:21:20) - FOMO - Advancing Test & Measurement Strategies in MedTech Manufacturing with Javier Olea of Averna(00:32:50) - Keynote Interview: Carl St. Bernard, CEO, Jupiter Endovascular

In this episode of DeviceTalks Weekly, Rob Binney, CEO of ShiraTronics, explains how the neurostimulation device is working to provide some relief for people suffering from chronic migraines. Binney’s career started in pharma, but he’s built a MedTech career at significant companies including AccessClosure, Intersect ENT before taking his first CEO role at Alydia Health. In our FOMO interview, Steven Mickelsen, MD, chief technology officer and founder of Field Medical, details the different challenges in taking on ventricular cardiac arrhythmias vs. atrial fibrillation where he built his monumental success. Dr. Mickelsen will also share Field Medical’s story at our DeviceTalks Cardiac Innovations Series taking place Feb 3-5. Register at DeviceTalks.com to watch live or on demand. MassDevice’s Chris Newmarker brings his Newmarker’s Newsmakers – Johnson & Johnson MedTech, Edwards Lifesciences, Distalmotion, Intuitive Surgical, Medtronic, and Boston Scientific. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:12) - Distalmotion secures funding from J&J to support Dexter rollout in ASCs(00:06:43) - Edwards gives up on $1.2B JenaValve acquisition(00:09:00) - Intuitive says daVinci systems ‘exceeded expectations,’ it wants more(00:11:12) - Medtronic has ‘significant firepower’ to boost M&A(00:13:08) - All the big news from Boston Scientific(00:20:10) - FOMO – Steven Mickelsen, MD, Founder, Field Medical(00:27:40) - Keynote Interview, Rob Binney, CEO, ShiraTronics

Innovation doesn’t happen by accident. It happens when leaders intentionally design the systems that allow curiosity, experimentation, and good ideas to survive. In this episode of the Women in MedTech podcast, host Kayleen Brown sits down with Dr. Rebecca Gottlieb, VP of Advanced Sensor Technologies at Biolinq, to explore what it really takes to build innovation engines inside regulated MedTech environments. From early clinical work with artificial heart patients, to more than two decades of sensor innovation at Medtronic, to leading advanced biosensing platforms at Biolinq, Rebecca explains why curiosity isn’t just a mindset — it’s a leadership strategy. Kayleen also welcomes Chris Dawson, Head of Biosensing at TTP PLC, to unpack what curiosity looks like in practice: how multidisciplinary teams explore what’s possible, retire risk early, and build systems that support innovation without compromising reliability or regulatory rigor. Thank you to TTP for your support, to learn more visit: https://www.ttp.com. Before you go, make sure to download your complimentary e-books from TTP today!  Rethinking Regulatory Compliance -  How to turn regulatory demands in MedTech into development strengths Optimising Bluetooth Connectivity in Implantable Medical Devices Automated Biosensor Testing for the Development of Continuous Health Monitors *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players:https://women-in-medtech.castos.com/subscribe Follow us on YouTube:https://www.youtube.com/@DeviceTalks Want access to the complete DeviceTalks Podcast Network (DTPN)?Follow us at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why innovation systems matter in MedTech(00:00:01) - Introducing in-studio guest, Chris Dawson, TTP(00:00:02) - What innovation looks like inside multidisciplinary teams(00:00:03) - Start of keynote interview with Rebecca Gottlieb, Biolinq(00:00:04) - From startup to Medtronic: scaling innovation across environments(00:00:05) - Internal venture programs: designing systems for ideas to surface(00:00:06) - Leadership as barrier removal, not control(00:00:07) - Why Rebecca chose Biolinq: platforms, microneedles, and possibility(00:00:08) - Rethinking glucose monitoring for Type 2 diabetes(00:00:09) - FDA De Novo clearance and sustaining teams through long timelines(00:00:10) - The future of biosensing: DNA-based receptors and new analytes(00:00:11) - Leadership reflections and closing: curiosity as an innovation engine

HAPPY NEW YEAR! Host Tom Salemi squeezes in that salutation one final time in our first episode of DeviceTalks Weekly. In this episode, Managing Editor Kayleen Brown shines the FOMO spotlight on a possible new approach to treating stroke victims. Liane Teplitsky, now executive chair of Executive Chair of the Board of Directors of Carvolix, explains how an early-stage robot could give more interventionalists the power to help stroke victims. Tom Salemi and MassDevice’s Chris Newmarker Vensana Capital Co-founder Justin Klein, MD, as a temporary member of the Newsmaker team where the review the highs and lows of the first full week of the year. Tom and Justin then talk about the state of MedTech venture capital starting with the HSBC annual report. Finally, Chris Newmarker hosts our keynote interview featuring Lisa Anderson, president of Paragonix Technologies, which is upending how donated organs are stored for transportation before transplantation. Newsmakers include the late Tom Fogarty, Teleflex, Staar Surgical, Alcon, W.L. Gore, Conformal, and Johnson & Johnson MedTech. You can access the HSBC report here - https://www.hsbcinnovationbanking.com/us/en/resources/2025-annual-venture-healthcare-report?cid=B:OSOC:10937621680:10893300135 Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:06:40) - Meet Justin Klein, MD, co-founder managing partner, Vensana Capital(00:08:42) - MedTech pioneer Dr. Tom Fogarty passes away at 91(00:14:28) - Teleflex announces leadership transition as CEO Liam Kelly departs, cuts 2025 revenue guidance(00:17:20) - Staar Surgical to terminate Alcon deal after stockholder vote W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:20:10) - W.L. Gore to acquire left atrial appendage device maker Conformal Medical(00:24:45) - Johnson & Johnson MedTech submits Ottava surgical robot to FDA(00:27:19) - Tom and Justin review HSCB report(00:46:54) - FOMO Interview with Kayleen Brown and Liane Teplitsky(00:57:38) - Keynote interview with Lisa Anderson, President, Paragonix Technologies

Happy New Year DeviceTalkers! We’re excited to start 2026, but not before give a proper goodbye to 2025 by picking our top tech, biggest newsmaker (company or person), and biggest news of the year. Listen the selection from our editorial team – Kayleen Brown, Jim Hammerand, Chris Newmarker, Tom Salemi, and Sean Whooley – and a special guest, Chris Landon, CEO of Natus Medical. Just before we share our final thought, Brown gets a glimpse of the future of Ambulatory Surgery Centers from Oliver Keown, MD, CEO and founder of Oath Surgical. They recording the FOMO interview at DeviceTalks West.  To all of our listeners, thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Thank you from Tom and Kayleen(00:05:05) - Overview of the Episode(00:07:00) - FOMO Interview – Oliver Keown, MD, CEO of Oath Surgical on ASCs(00:17:20) - 2025 Year in Review(00:19:40) - Introduction of Guest Panelist – Chris Landon, CEO, Natus Medical(00:25:20) - Our choices of medical technology of the year(00:47:50) - Newsmaker of the year – Company or Individual(01:01:40) - Biggest news story of the year

In this episode of the DeviceTalks Weekly podcast, we give the entire stage to Medtronic’s surgical robotics business in honor of the FDA’s approving the Hugo RAS system for urological procedures. This episode is sponsored by Confluent Medical Technologies. Visit http://confluentmedical.com/ for more information. First, MassDevice editor Chris Newmarker asks James Porter, MD, a practicing surgeon and CMO of Medtronic’s surgical business, why he sees as a better alternative for hospitals and surgeons. Then, Host Tom Salemi visits with Rajit Kamal, the VP of the company’s surgical robotics building to learn what’s next. How will the company take on the massive incumbent, Intuitive. We’ll also visit with Gayle Grimes, author of MassDevice’s Medtech Market Intelligence Report on surgical robotics. Go here to learn more. https://www.massdevice.com/product/robotic-surgery/ This week’s Newmarker’s Newsmakers are CMR Surgical, Johnson & Johnson MedTech, Olympus, Nephrodite, and Medline. Go here to listen to Rajit Kamal’s first appearance on the DeviceTalks Weekly podcast: https://www.devicetalks.com/velys-inhance-and-other-reasons-why-depuy-synthes-sees-ortho-opportunities-2021s-top-dtw-episodes/ *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:55) - Surgical Report Gayle Grimes(00:10:56) - CMR Surgical wins FDA clearance for next-gen Versius Plus surgical robot in cholecystectomy(00:13:22) - Johnson & Johnson MedTech EP leader Bodner explains recent ASC boost for PFA(00:15:03) - Olympus launches second medtech investment fund with $150M(00:16:08) - Continuous dialysis implant wins FDA Breakthrough Device Designation(00:18:33) - Medline prices $7B IPO, begins trading on Nasdaq(00:23:00) - Confluent Medical, Part 1(00:26:40) - Interview with James Porter, MD, CMO, Robotic Surgical Technologies & Digital Technologies, Medtronic(00:52:43) - Confluent Medical, Part 2(00:56:22) - Interview with Rajit Kamal, VP and GM, Robotic Surgical Technologies, Medtronic

Earned trust becomes leadership capital — and in MedTech, it compounds faster than most leaders realize. In this episode of the Women in MedTech podcast, host Kayleen Brown talks with Edwards Lifesciences’ Sarah Huoh, Corporate Vice President of Public Affairs, about why trust has to be built and demonstrated long before it can be communicated — and what it takes to earn credibility across patients, policy, and teams. Kayleen also welcomes Brittany Mai, Marketing Manager at Confluent Medical Technologies, to discuss what trust looks like across the MedTech ecosystem — how strong partnerships get built, how alignment happens across organizations, and why execution depends on credibility that’s earned over time. Thank you to Confluent Medical Technologies for your support. Visit ➡ https://confluentmedical.com/ *** Enjoy this podcast? Follow Women in MedTech with Kayleen Brown on all major podcast players: https://women-in-medtech.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Why trust matters in MedTech(00:02:13) - Introducing In-studio guest, Brittany Mai, Confluent Medical Technologies(00:17:34) - Start of Keynote Interview with Sarah Huoh, Edwards Lifesciences(00:18:31) - Leadership foundations: first job lessons that still show up in the C-suite(00:29:32) - Career moves with strategy: how Sarah chose roles that widened her impact(00:32:44) - Public affairs as a business function: reputation, policy, and patient trust(00:38:30) - “Team of teams” leadership: alignment, execution, and internal credibility(00:39:23) - Operating at global scale: keeping 16,000 employees anchored on patients(00:42:18) - Patient education as market reality: reducing fear, friction, and confusion(00:48:49) - Trust as leadership capital: demonstrated behavior, not messaging(01:06:52) - Conclusion: key takeaways on earning trust that compounds

In this episode of DeviceTalks Weekly, Host Tom Salemi gets the dos and don’t’s of entrepreneurship with serially successful MedTech leader Ray Cohen. In this keynote address from DeviceTalks West, Cohen delivers a master class on how to build a successful MedTech, using Boston Scientific’s $3.7 billion acquisition as a case study. DeviceTalks Managing Editor Kayleen Brown explores the future of connected health with Dr. Sarah Matt, author of the new book, The Borderless Healthcare Revolution. Go to DrSarahMatt.com to order the book. Thank you to Lighteum Medical for sponsoring this episode of DeviceTalks Weekly. Go to http://lighteum.com/ for more information. Want to meet with Lighteum Medical in person at MD&M West? Book time with them here: https://calendly.com/lighteum-medical/mdmwest  MassDevice’s Chris Newmarker kicks us off with his Newmarker’s Newsmakers – SS Innovations, Boston Scientific, Teleflex, Resmed, Telefex Medical. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:29) - Newmarker's Newsmakers(00:18:51) - Part 1 of interview with Jose Maeso, CTO of Lighteum Medical(00:22:35) - FOMO Interview with Dr. Sarah Matt(00:33:28) - Insights from Ray Cohen on MedTech Success(00:44:18) - Key Elements for Starting a Company(00:48:12) - Part 2 of the interview with Lighteum Medical(00:50:50) - The Role of Clinical Support and Physician Champions(01:00:32) - Navigating the IPO Process and Market Dynamics(01:09:27) - The Acquisition by Boston Scientific and Lessons Learned(01:14:31) - Key Takeaways for Aspiring Entrepreneurs

In this episode of Ortho Innovation Talks, host Tom Salemi sits with Suneethi Gudapati, VP of Research & Development, Enovis™ Bracing & Supports, to discuss how her team is advancing the engineering behind braces and supports across the orthopedic continuum of care. Gudapati shares how Enovis evaluates materials, designs, and patient feedback to improve comfort, usability, and clinical performance across its extensive bracing portfolio, which spans postoperative and preventive use cases. She also discusses how her R&D teams partner across the company to explore future opportunities, from new composite materials to potential AI and connected-health applications, while maintaining a strong focus on unmet needs and the aging, increasingly active patient population. Missed a DeviceTalks Tuesdays webinar? Catch up, on-demand, at: https://gateway.on24.com/wcc/experience/elitewtwhmedia/2927718/4415884/devicetalks-tuesdays for everything you missed in 2025. *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode, MassDevice Editor Chris Newmarker talks with Alan Cheng, MD, chief medical officer at Medtronic’s cardiac rhythm management business about the future of medical-grade cardiac monitors like Medtronic LINQ monitors. These tiny devices, placed just under the skin, can collect heart rhythm data and transmit it directly to doctors, like Cheng, who is a practicing electrophysiologist. The LINQ II has a battery life of more than four years. How does its functionality compare to consumer monitors, and can LINQ someday find a role as a health tracking tool sold over the counter? Thank you to Resonetics for sponsoring this podcast episode. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8 In our FOMO interview, Jim Hammerand, managing editor of medical design and outsourcing, talks with Ken Charhut, CEO of Foldax about that start-ups innovative heart valve polymer and manufacturing process. But we kick things off with this week’s Newmarker’s Newsmakers discussion with Host Tom Salemi and Chris Newmarker. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:30) - #5 - Surgical robotics market will double over the rest of the decade(00:07:23) - #4 - CMS adds reimbursement for cardiac ablation in ASCs(00:09:14) - #3 - Former Stryker robotics leader named CEO at Olympus' Swan EndoSurgical robotics play and Stryker promotes Spencer Stiles to president, COO(00:13:49) - #2 - Medtronic gets FDA nod for Hugo surgical robot in urologic procedures(00:16:35) - #1 - Johnson & Johnson MedTech to shift to business unit-led structure in 2026(00:20:18) - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics(00:23:15) - FOMO – Ken Charhut, CEO, Foldax(00:33:48) - Keynote interview Alan Cheng, MD, chief medical officer, CRM, Medtronic(00:46:25) - Conclusion - Interview with Eric Veit, Vice President, Nitinol Business Development, Resonetics

In this week’s DeviceTalks Podcast, we’re spotlighting two very different leaders shaping the future of surgical robotics. Huge thanks to our sponsor, Murata. First up in our FOMO interview, Tom Salemi speaks with Iman Jeddi, senior vice president and general manager of da Vinci platforms and product operations at Intuitive. Jeddi—who closed out our joint keynotes at DeviceTalks West and RoboBusiness—shares deep insight into Intuitive’s long-term vision and what’s next for the surgical robotics front-runner. Then in our keynote interview, Salemi talked with Anne Osdoit, CEO of Moon Surgical. Osdoit breaks down how the company’s Maestro system—designed to move and stabilize laparoscopic tools—is gaining traction in hospitals and ASCs and carving out a new category in robotic surgery. To learn more about the work Murata is doing in medical devices you can download Murata's Medical Applications Brochure HERE or go to their website murata.com. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, we hear from two of MedTech’s most powerful leaders, each representing different ends of the innovation timeline. Tim Schmid, executive vice president and worldwide chairman of Johnson & Johnson MedTech, lays out the global leaders plan to lead in cardiovascular, surgery, vision, surgical robotics and other high growth businesses. Schmid opened our DeviceTalks West conference last month where he was interviewed by Host Tom Salemi. Thank you to Vantedge Medical for sponsoring this episode. For more information on how Vantedge works with medical device companies, visit: https://vantedgemedical.com/ Then, Josh Makower, the Yock Family Professor and professor of bioengineering at the Stanford Mussallem Center for Biodesign sits down in a FOMO interview with Managing Editor Kayleen Brown. Makower, a battle-tested advocate for MedTech innovators, writes a prescription for helping start-ups, calling on OEMs to provide more support. Makower also keynoted the event. MassDevice editor Chris Newmarker kicks things off with this week’s Newmarker’s Newsmakers – Stryker, Boston Scientific, Siemens Healthineers, Medtronic, Solventum, Abbott and Exact Sciences. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:04:35) - Stryker VP, GM for Robotics and Enabling Technologies is departing(00:06:16) - Boston Scientific, Siemens Healthineers ink 4D ICE catheter development deal(00:08:23) - Do we have bubbles in MedTech?(00:11:26) - Medtronic has a strong Q2 beat on PFA strength(00:16:01) - Solventum to acquire soft tissue repair company Acera Surgical, repurchase $1B in shares(00:18:20) - Abbott confirms plans to acquire Exact Sciences for $21B(00:26:26) - Vantedge Medical – How to Recruit and Retain Talent(00:28:29) - FOMO with Josh Makower - Stanford Mussallem Center for Biodesign(00:37:08) - Vantedge Medical – The importance of metals(00:42:27) - Interview with Tim Schmid, Johnson & Johnson MedTech(00:51:31) - Vantedge Medical – Supply chain concerns

In this episode of Ortho Innovation Talks, host Tom Salemi sits with Brad Batte, President of Enovis™ Regeneration, to discuss how the division is transforming post-operative recovery through bone growth stimulation. He also discusses at-home device compliance, clinical outcomes, and how Enovis is expanding its innovation pipeline to support patients across the full continuum of care. This episode is brought to you by DeviceTalks Tuesdays. Join us for a free week-long webinar series: DeviceTalks "Materials & Manufacturing." *** Enjoy this podcast? Follow Ortho Innovation Talks on all major podcast players: https://ortho-innovation-talks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of the DeviceTalks Weekly podcast, Jian Zheng, founder and CEO of Noah Medical, has found entrepreneurial success in robotics, medical devices and a companies that combine both including Intuitive and Auris. Now, Zheng leads Noah Medical, a robotic bronchoscopy company that’s trying to develop a superior way of diagnosing and treating lung cancer. How does Noah see itself beating Johnson & Johnson MedTech and Intuitive in this competitive space? What areas could Noah focus on next? And where how did the company get the Noah name? Host Tom Salemi asks these questions and more. In this week’s FOMO, Sonia Valdes, vice president of life sciences claims at Medmarc, reveals some of the unseen risks and unintended benefits facing the medical device industry coping with new tariffs on medical device imports. Finally, Chris Newmaker of MassDevice delivers this week’s Newsmakers – Synchron, InBrain, Inspire Medical, Zimmer Biomet, and Olympus. This episode comes to you courtesy of Medmarc. To learn more, visit: https://medmarc.com/ *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:05:43) - Synchron raises $200M Series D to support BCI commercialization, next-gen tech(00:08:30) - InBrain, Microsoft team up on AI for neurology, BCI tech(00:11:40) - Inspire Medical faces investor class action over Inspire V launch allegations(00:13:28) - Deloitte accuses Zimmer Biomet of filing ‘through the looking glass’ suit(00:16:18) - Olympus to cut 2,000 jobs as it unveils new corporate strategy, executive additions(00:23:45) - FOMO – Sonia Valdes, vice president, life sciences claims, Medmarc(00:35:15) - Keynote Interview – Jian Zhang, CEO, Noah Medical

Artificial Intelligence is transforming healthcare—and Olympus is at the forefront. In this episode, Chief Digital Officer Slawek Kierner and Director of Marketing, GI Digital Solutions Neviana Terzieva share their journeys into medtech and discuss how Olympus is integrating AI into endoscopy, clinical decision-making, and workflow optimization.  Chapter 1: Meet the Guests  Slawek Kierner and Neviana Terzieva discuss their backgrounds in software, healthcare, and digital innovation, and what drew them to Olympus.  Chapter 2: Defining AI in MedTech  What does “AI” really mean for medical devices?  How AI supports the quintuple aim: better outcomes, lower costs, improved experiences, increased access, and reduced burnout.  Chapter 3: Blended Intelligence & Burnout  The concept of “blended intelligence”-- AI as a complement to human expertise.  Chapter 4: Olympus® Technologies in Action  Spotlight on EDOF™ scopes, CADDIE™ polyp detection software, and the OLYSENSE™ platform.  Real-world examples of AI enhancing clarity, precision, and detection rates in GI procedures.  Chapter 5: Clinical Impact & Physician Reception  How AI augments, not replaces, clinical decision-making.  Physician perspectives on adopting new technology and maintaining high standards of care.  Chapter 6: The Future of AI at Olympus  Vision for saving lives, supporting detection rates, and empowering healthcare teams.   For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas.    ADDITIONAL RESOURCES:  Meet OLYSENSE™ -- Olympus’ intelligent endoscopy platform powered by AI: https://medical.olympusamerica.com/olysense

In this episode of DeviceTalks Weekly, Host Tom Salem welcomes back Rob Kowal, MD, VP and general manager, cardiac pacing at Medtronic. You’ll hear how Dr. Kowal grew into the new role as business leader and gain a stronger appreciation for Medtronic’s flagship cardiac pacing business. Smaller devices and new innovation are helping to find new ways to deploy cardiac pacing. How else can cardiac pacing devices save lives? Dr. Kowal previously appeared on MedtronicTalks when he was vice president, medical affairs and CMO of cardiac rhythm and heart failure. Find the MedtronicTalks Podcast here - https://www.devicetalks.com/learn-how-medtronic-is-moving-to-mark-arctic-front-a-first-line-treatment-for-atrial-fibrillation/ Thank you to Confluent Medical Technologies for sponsoring this episode of DeviceTalks Weekly. To learn how their material science technologies and high performance manufacturing help bring your medical device designs to life go to ConfluentMedical.com or nitinol.com. MedTech Analyst Chrystal Larsen joins MassDevice Editor Chris Newmarker and Salemi on this week’s newsmakers. Before diving into the week’s top MedTech Stories, Larsen discusses the debut of MassDevice’s MedTech Market Reports on Continuous Glucose Monitoring (CGM) Market. You can find more information about the report here: https://www.massdevice.com/product/continuous-glucose-monitoring-cgm-market/  Top newsmakers of the week are Aqua Medical, Coherence Neuro, Medtronic, Smith & Nephew, and Zimmer Biomet. Thanks for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - New DeviceTalks Podcast!(00:09:10) - New MassDevice Report(00:20:21) - MassDevice’s Newmarker’s Newsmakers(00:35:14) - Confluent Medical’s Impact on MedTech(00:37:47) - Keynote conversation with Rob Kowal, MD, VP and general manager, cardiac pacing, Medtronic

Empathy is more than a leadership trait—it’s a business advantage. In this season opener of Women in MedTech, host Kayleen Brown talks and Medtronic’s Nina Goodheart, SVP & President of Structural Heart & Aortic talk about Medtronic's focus on women's heart health and makes the business case for empathy in MedTech. Kayleen also welcomes Beth Harrison Meyer, SVP of Global Marketing at Aptyx, to unpack what empathy looks like inside companies and why it’s critical to innovation and culture. Thank you to Aptyx for your support. Visit ➡ https://www.aptyx.com Referenced in this episode: – Medtronic’s Letter to My Mother campaign: https://www.medtronic.com/en-us/c/patients-caregivers/pan-cardiovascular/letter-to-my-mother.html – Kayleen’s article in Medical Design & Outsourcing: https://www.medicaldesignandoutsourcing.com/medtronic-nina-goodheart-cardiovascular-deaths-women-rwe-smart-trial/ Enjoy this episode? Follow Women in MedTech → https://women-in-medtech.castos.com/subscribe and subscribe on YouTube → https://YouTube.com/@DeviceTalks to catch every conversation. #PurpleSuit Access the full DeviceTalks Podcast Network → https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Empathy to Self, Empathy to Ecosystem(00:02:45) - The Power of Mentorship and Sponsorship(00:05:30) - Building the Aptyx Culture of Collaboration(00:10:15) - Insights into the Keynote Interview with Nina Goodheartt(00:17:00) - What Empathy Looks Like in Product Development(00:22:15) - Designing for Equity: Who Are We Not Treating Yet?(00:27:10) - The Business Case for Empathy in MedTech(00:28:17) - Start of Interview with Medtronic's Nina Goodheart(00:36:30) - Using AI to Advance Health Equity (The ALERT Study)(00:49:30) - Medtronic's Letter to My Mother: Women’s Heart Health Awareness(00:55:15) - Redefining Leadership — Empathy as Smart Business

In this episode of DeviceTalks Weekly, Scott Miller, CEO of GE HealthCare’s Solutions for Enterprise Imaging, joins Managing Editor Kayleen Brown to explore how cloud technology and AI are transforming medical imaging. Miller discusses the launch of Genesis, GE HealthCare’s cloud-native imaging platform that enables secure data access, reduces clinician burnout, and improves efficiency across health systems. Together, they look ahead to a future of smarter, more connected care—where technology expands access, enhances collaboration, and supports truly personalized medicine for patients everywhere. But we’ll start off with MassDevice Editor Chris Newmarker’s Newsmakers – Zimmer Biomet, Tandem, Petal Surgical, Medline, Medtronic and the GREAT COMMONWEALTH of Massachusetts. Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:02:30) - Introducing this week’s keynote(00:08:56) - Zimmer Biomet wins FDA breakthrough nod for first iodine-treated hip replacement system(00:10:56) - Tandem launches t:slim X2 pump with Abbott FreeStyle Libre 3 Plus(00:13:15) - Incisionless surgical robotic tech startup Petal Surgical emerges from stealth with $10M Series A(00:15:30) - Medline officially files for IPO(00:17:12) - Medtronic gains millions in tax incentives for Massachusetts expansion(00:21:32) - Scott Miller, CEO of GE HealthCare’s Solutions for Enterprise Imaging

In this episode of AbbottTalks, hosts Tom Salemi and Kayleen Brown sit down with Dr. Finn Gustafsson, Chief Medical Officer for Abbott’s Heart Failure business, to discuss how Abbott’s technologies are transforming care across every stage of heart failure. Dr. Gustafsson—who spent decades in academic medicine before joining Abbott—explains how the company’s CentriMag™ System, HeartMate 3™ LVAD, and CardioMEMS™ HF System stabilize, sustain, and empower patients in each phase of the condition. The conversation explores what sets Abbott’s approach apart: early intervention through pulmonary artery pressure monitoring, mechanical circulatory support for critically ill patients, and long-term LVAD therapy that’s helping extend lives beyond five years. Lastly, Dr. Gustafsson shares insights from pivotal studies such as MOMENTUM 3, ARIES, and ASPIRE, which demonstrate how Abbott’s focus on evidence and patient experience is advancing the entire field. This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/ Thank you for listening to the AbbottTalks podcast! *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/ Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:00) - Exploring Abbott's Heart Failure Business and Digital Healthcare Innovation(00:03:36) - Transforming OEMs with Connectivity and Predictive Maintenance(00:05:54) - Dr. Finn Gustafsson's Journey from Academia to Abbott Heart Failure(00:11:20) - Understanding Heart Failure and Abbott's Heart Failure Portfolio(00:18:03) - Heart Monitoring Devices Enhance Patient Care and Empowerment(00:25:41) - AI-Driven Healthcare Innovation and Regulatory Navigation(00:29:20) - Advancements and Patient Impact of HeartMate 3 in Heart Failure(00:41:19) - Reducing Bleeding Risks in HeartMate 3 Patients Without Aspirin(00:42:45) - Advancements and Future Directions in LVAD Technology and Treatment(00:45:16) - Exploring MedTech Innovations and Patient Choices in Heart Devices

In this episode of DeviceTalks Weekly, Dr. Vishwa Srivastava shares his unique journey to leading one of the more dynamic surgical robotics companies in MedTech. Dr. Srivastava’s path takes him across disciplines and geographies from anthropology to medicine. He discusses the founding of SS Innovations, which has developed the Mantra series of surgical robotics systems that the company hopes can make a robotic surgery more accessible and affordable. Dr. Srivastava emphasizes the importance of telesurgery and the future of surgical robotics, highlighting the challenges and innovations in the field. Host Tom Salemi opens this episode with MassDevice Editor Chris Newmarker to review some of the top stories in MedTech over the past two weeks including – Olympus, Solventum, Boston Scientific, DePuy Synthes, and Hologic. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:07:23) - How Olympus views ‘different’ Swan EndoSurgical surgical robotics play(00:09:14) - Boston Scientific to acquire Nalu Medical for $533M(00:12:25) - Johnson & Johnson to separate DePuy Synthes Orthopaedics business(00:15:48) - Solventum hires Baxter EVP and COO Heather Knight for new C-suite role(00:18:26) - Hologic to be acquired by private equity firms Blackstone, TPG for up to $18.3B(00:25:22) - Keynote Interview, Vishwa Srivastava, MD - President & COO - South Asia(00:50:00) - Why did SS Innovations International need to be started.(01:09:00) - The case for surgical robotics(01:22:02) - Is telesurgery necessary?

In this episode of DeviceTalks Weekly, the DeviceTalks West on-site crew – Tom Salemi, Kayleen Brown, and Jim Hammerand – share their favorite moments and lessons of the two-day event. We’ll talk about keynotes, hot technologies, and the power of having and being a mentor. Thank you to our amazing sponsors, speakers, and attendees! Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

See how ambulatory endoscopy centers (AECs) are reshaping GI care—combining independent physicians’ personal investment with “nimble” innovation and improved patient access. In this episode, Olympus’ Director of Strategic Marketing for GI Diane Locher, joins Dr. Nalini Guda of GI Associates and Dr. Neil Parikh of CTGI & GI Alliance to discuss the unique challenges and opportunities of AECs. Learn how these centers streamline procedures, foster team-based care, and rapidly adopt new technologies, all while tackling access deserts and supporting physician well-being.  Chapter 1: Meet the Guests  Diane Locher shares her journey to Olympus and her focus on supporting AECs.  Dr. Nalini Guda and Dr. Neil Parikh introduce their backgrounds, independent practice models, and what drew them to GI.  Chapter 2: Defining AECs  What sets AECs apart from traditional ASCs and hospitals?  How “skin in the game” or independence drives efficiency, ownership, and patient-centered care.  The importance of nimbleness and adaptability in adopting new technologies.  Chapter 3: Access, Innovation, and Teamwork  Tackling “colonoscopy deserts” and improving patient access.  The team approach: physicians, nurses, anesthesiologists, and staff working toward a single goal.  How AECs serve as “innovation playgrounds” for piloting new GI technologies.  Chapter 4: Burnout, Well-being, and Technology  Physician burnout and how independent models help mitigate it.  The role of ambient listening and AI-powered documentation in streamlining workflow.  Training, onboarding, and staff support as critical components of AEC success.  Chapter 5: The Future of GI in AECs  Expanding the menu of procedures: from colorectal screening to endobariatrics and pancreaticobiliary care.  The evolving partnership between industry, physicians, and healthcare systems.  Advocacy and support to enable broader access.    For more episodes by OlympusTalks, please visit olympusamerica.com/podcasts.  This podcast has been paid for by Olympus Corporation of the Americas. The views and experiences shared are those of Dr. Nalini Guda and Dr. Neil Parikh, paid consultants of Olympus Corporation and its affiliates. Olympus makes no representations regarding the accuracy or applicability of the content and disclaims all liability arising from its use. Product performance may vary, and techniques, instruments, and clinical decisions are unique to each facility and practitioner. Always refer to the Instructions for Use (IFU) and applicable labeling for guidance, risks, and cautions.  ADDITIONAL RESOURCES:  Take your AEC to the next level—partner with Olympus. Visit our site for training, resources, and portfolio solutions tailored to your needs. Visit, Ambulatory Surg...

In this episode of DeviceTalks Weekly, Dr. Steven Mickelsen shares his unique journey to becoming a leading figure in the MedTech industry. He discusses the evolution of pulse field ablation technology, the challenges faced in the field of electrophysiology, and his decision to start Field Medical, a follow up story to the historically successful Farapulse. Host Tom Salemi conducts the interview. This episode is sponsored by Viant. Managing Editor Kayleen Brown interviews Anthony Misener, GM, design and development, Viant. To learn more about Viant, visit https://viantmedical.com/. Sarah Matt, MD, a practicing physician, former tech exec, and now author sits in the virtual FOMO studio to give a sense of where Connected Health is headed. Dr. Matt will sit on a panel at DeviceTalks West exploring how deeply connected technologies have penetrated MedTech and the clinical setting. See Drs. Matt and Mickelsen at DeviceTalks West. Go to West.DeviceTalks.com to see the agenda. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:01:35) - Women in MedTech Breakfast Update(00:08:11) - Details Steven Mickelsen, MD’s talk at DeviceTalks West(00:13:00) - FOMO with Physician, Tech Guru and Author Sarah Matt, MD(00:25:26) - Anthony Misener, general manager, design and development, Viant(00:28:14) - Keynote Interview - Steven Mickelsen, MD, CEO of Field Medical

In this episode of DeviceTalks Weekly, Cognito Therapeutics’ Christian Howell conveys a deep sense of service that brought him to the MedTech industry. Host Tom Salemi talks with Howell about his Navy service, including a mission targeting pirates in the Persian Gulf on Sept. 11, 2001. From there, Howell gained a unique—and faraway—view of the tragic events that changed the world. He carried those lessons into roles at Covidien and Medtronic, where he helped drive Medtronic’s move into value-based healthcare. Howell is now leaning into that same call of service at Cognito Therapeutics, an MIT-launched startup working to prove that lights and sounds can stimulate the brain to slow the onset of dementia. The technology could become a platform for new brain therapeutics. You can learn more about Cognito’s technology at DeviceTalks West, where Chief Medical and Scientific Officer Ralph Kern will sit on a panel. Visit West.DeviceTalks.com for more information and to register. This week’s FOMO interview spotlights ivWatch, a new device for monitoring intravenous lines. MassDevice Editor Chris Newmarker delivers this week’s Newmarker’s Newsmakers, featuring CorWave, Medtronic, Olympus, Siemens Healthineers, and Zimmer Biomet. Thank you for listening to DeviceTalks Weekly. *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of IntuitiveTalks, Host Tom Salemi visits Intuitive’s Atlanta hub to sit down with Brian Miller, executive vice president and chief digital officer.   Miller, who witnessed the first telesurgery procedure in 2001, shares his perspective on how surgical robotics has advanced beyond many early barriers to long-distance surgery. He emphasizes that adoption must be driven by user needs, not hype, with success hinging on meeting the daily realities of surgeons, patients, and health systems. This practical, patient-centered conversation explores what’s next for telesurgery.   This conversation comes to you courtesy of Blue Goat Cyber. To learn more, visit: https://bluegoatcyber.com/   *** Enjoy this podcast? Follow the DeviceTalks Podcast Network, home of IntuitiveTalks, on all major podcast players: https://devicetalks.castos.com/subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an future episode.

In this episode of DeviceTalks Weekly, Managing Editor Kayleen Brown talks with Jyoti Gera, CEO of CardioVascular and Interventional Solutions for GE HealthCare, about her journey into the MedTech industry, the significance of cardiovascular health, the challenges faced in patient care, and the innovative solutions GE HealthCare is implementing to improve outcomes. Jyoti emphasizes the role of artificial intelligence in enhancing early detection and personalizing treatment, while also outlining the future of cardiology care as more connected and efficient. The conversation highlights the importance of collaboration in the healthcare ecosystem to address the growing burden of cardiovascular disease. This week’s FOMO guest Chris Steadham, vice president of technology at Aptyx, unpacks the evolution of implants and delivery systems. He emphasizes the importance of co-developing delivery systems alongside implants to ensure optimal performance and physician satisfaction. The discussion also touches on the impact of emerging technologies like AI and robotics in reshaping interventional procedures. For more information, go to https://aptyx.com/ Paul Grand, CEO of MedTech Innovator, commandeers the Newmarker’s Newsmakers to reveal the Finalists for MedTech Innovator’s finalists for its early-stage and execution awards. Read them here at MassDevice.https://www.massdevice.com/medtech-innovator-names-2025-grand-prize-finalists/ Thank you for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:00:04) - Keynote Interview with Jyoti Gera, CEO, CardioVascular & Interventional Solutions, GE HealthCare(00:02:45) - Welcome Paul Grand of MedTech Innovator(00:05:15) - MTI’s Execution Award Finalists(00:16:15) - MTI’s Early-stage Award Finalists(00:35:05) - FOMO with Chris Steadham, vice president, technology, Aptyx

In this episode of DeviceTalks Weekly, CMR Surgical CEO Massimiliano Colella joins Editorial Director Tom Salemi to share his wide-ranging journey through the MedTech industry. He talks about his experiences across global markets, his move from MedTech into the provider world, and why partnerships are critical to healthcare. Colella also dives into the future of surgical robotics, the importance of digital transformation, and CMR’s strategic vision moving forward. Sticking with the surgical robotics theme, our FOMO guest this week is Maggie Nixon, CEO of Capstan Medical, who sits down with Managing Editor Kayleen Brown. A big thanks to Vantedge Medical for sponsoring this episode of DeviceTalks Weekly. Learn more at https://vantedgemedical.com/ Be sure to catch Kayleen’s two-part interview with Cassandra Haupers, Director of Global Business Development, Machining at Vantedge Medical. (Want even more? Revisit their DeviceTalks West session from last year go to: https://event.on24.com/wcc/r/4612496/CCDA4762BD61D414E6C0DBC1D002216D?partnerref=DTWeekly .) Stick around for MassDevice’s Chris Newmarker’s Newsmakers listed in the timeline below. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe   Episode rundown: 2:11 – Tom’s beef with Minnesota6:06 – Smith+Nephew reports positive clinical evidence for bioinductive implant8:39 – Dexcom CEO takes temporary leave of absence10:27 – Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project13:24 – Siemens Healthineers, Stryker partner on neurovascular robotics17:31 – Medtech Big 100: The world’s largest medical device companies23:00 – [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical25:00 – FOMO – Maggie Nixon, Capstan Medical36:41 – Keynote – Massimiliano Colella, CMR Surgical55:58 – [Part 2] Cassandra Haupers, Vantedge Medical Chapters (00:02:11) - Tom’s beef with Minnesota(00:06:06) - Smith+Nephew reports positive clinical evidence for bioinductive implant(00:08:39) - Dexcom CEO takes temporary leave of absence(00:10:27) - Zimmer Biomet sues Deloitte for \$172M over ‘disaster’ project(00:13:24) - Siemens Healthineers, Stryker partner on neurovascular robotics(00:17:31) - Medtech Big 100: The world’s largest medical device companies(00:23:00) - [Part 1] Cassandra Haupers, Director of Global Business Development, Machining, Vantedge Medical(00:25:00) - FOMO – Maggie Nixon, Capstan Medical(00:36:41) - Keynote – Massimiliano Colella, CMR Surgical(00:55:58) - [Part 2] Cassandra Haupers, Vantedge Medical

In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Santosh Prabhu, PhD, Divisional Vice President of Product Development for Abbott’s Structural Heart business, to discuss the company’s expanding portfolio and its impact on patients. Prabhu outlines Abbott’s transcatheter solutions, including MitraClip, TriClip, and Navitor, and shares updates on next-generation mitral and tricuspid valve replacement programs. He highlights how imaging advancements, new materials, and design innovations are enabling minimally invasive therapies for patients who are not candidates for surgery. The conversation also touches on Abbott’s HeartMates program, which connects and supports patients and families as they navigate cardiovascular conditions. Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/. Thank you for listening to AbbottTalks!  *** Enjoy this podcast? Follow AbbottTalks on all major podcast players: https://abbotttalks.castos.com/. Subscribe + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe

In this episode of DeviceTalks Weekly, Host Tom Salemi and managing editor Kayleen Brown recap their recent West Coast tour—including a stop at the Santa Clara Convention Center, home of DeviceTalks West on Oct. 15–16. Register at West.DeviceTalks.com. They also share highlights from the MedtechVISION conference, including Kayleen’s brush with greatness—the winner of the Ferolyn Powell Award. This week’s FOMO segment features Medtronic’s Julie Cole, who updates listeners on the latest challenges and opportunities in the ASC sector in a conversation with DeviceTalks producer Emira Wininger. In the keynote interview, Tom sits down with Bioretec’s new CEO, Sarah van Hellenberg Hubar-Fisher, to talk about her career in MedTech and her decision to lead the company’s mission to transform orthopedic healing with advanced materials and bioabsorbable implants. Thanks for listening to DeviceTalks Weekly! *** Enjoy the show? Follow DeviceTalks Weekly on all major podcast players + Follow us on YouTube.com/@DeviceTalks to ensure you never miss an episode. Want access to the complete DeviceTalks Podcast Network (DTPN)? Follow us today at https://devicetalks.castos.com/subscribe Chapters (00:03:30) - MedtechVISION and the Ferolyn Powell award(00:06:38) - the Ferolyn Powell award winner(00:09:00) - Exciting Updates and Keynotes at DeviceTalks West Conference(00:12:55) - Connected Health DeviceTalks Tuesdays series(00:15:18) - FOMO – Medtronic’s Julie Cole on the Future of ASCs and MedTech Innovation(00:25:40) - Keynote Interview - Sarah Hubar-Fisher, CEO of Bioretec(00:32:28) - Challenges and Triumphs in MedTech Regulatory and Market Adoption(00:35:37) - Hubar-Fisher’s Journey from Corporate to Venture Capital and BioRetech(00:41:40) - BioRetech's Innovative Magnesium Alloy Implants for Orthopedic Solutions(00:49:06) - Bioretech's Journey to Market Leadership in Bioabsorbable Implants